Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer [2] (multiple letters)

Kadri Altundag; Ozden Altundag; Paolo Morandi; Mehmet Gunduz; Natasha M. Tiffany; Emily M. Wersinger; Tomasz M. Beer; Mark Garzotto

doi:10.1016/j.urology.2004.06.005

Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer [2] (multiple letters)

Kadri Altundag, Ozden Altundag, Paolo Morandi, Mehmet Gunduz, Natasha M. Tiffany, Emily M. Wersinger, Tomasz M. Beer, Mark Garzotto

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	211-212
Number of pages	2
Journal	Urology
Volume	65
Issue number	1
DOIs	https://doi.org/10.1016/j.urology.2004.06.005
State	Published - Jan 2005

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.urology.2004.06.005

Cite this

@article{6cc0ce27c72e40ec806a2c25af0f8689,

title = "Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer [2] (multiple letters)",

author = "Kadri Altundag and Ozden Altundag and Paolo Morandi and Mehmet Gunduz and Tiffany, {Natasha M.} and Wersinger, {Emily M.} and Beer, {Tomasz M.} and Mark Garzotto",

year = "2005",

month = jan,

doi = "10.1016/j.urology.2004.06.005",

language = "English (US)",

volume = "65",

pages = "211--212",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer [2] (multiple letters)

AU - Altundag, Kadri

AU - Altundag, Ozden

AU - Morandi, Paolo

AU - Gunduz, Mehmet

AU - Tiffany, Natasha M.

AU - Wersinger, Emily M.

AU - Beer, Tomasz M.

AU - Garzotto, Mark

PY - 2005/1

Y1 - 2005/1

UR - http://www.scopus.com/inward/record.url?scp=12844278554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12844278554&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2004.06.005

DO - 10.1016/j.urology.2004.06.005

M3 - Letter

C2 - 15667906

AN - SCOPUS:12844278554

SN - 0090-4295

VL - 65

SP - 211

EP - 212

JO - Urology

JF - Urology

IS - 1

ER -

Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer [2] (multiple letters)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this